Halozyme Therapeutics (HALO)

Common Shares
Sell: $77.68|Buy: $79.44|Change: 2.52 (3.28%)

Cash flow

Operating cash flow
Taxation
Investing activities
Financing
Foreign exchange adjustments
Opening balance